RxDoctor Payments Data

Nathan King

Psychiatric/Mental Health · Pittsburgh, PANPI 1548934128

Payments from drug & device makers

$2,862in general payments, 2019–2025

Across 156 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$679
  • Alkermes, Inc.$396
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$240
  • Lundbeck LLC$237
  • Otsuka America Pharmaceutical, Inc.$190
  • Neurocrine Biosciences, Inc.$185
  • plus $936 from 11 others

What the payments were for

  • Food & beverage$2,77997%
  • Education$843%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,862 in reported general payments places this provider in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$7,468
Medicare patients
13
Services billed
83

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine11$125,255
Lurasidone Hcl24$10,540
XanaxAlprazolam11$6,608
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine45$4,014
VyvanseLisdexamfetamine Dimesylate11$3,682
Aripiprazole65$3,562
Venlafaxine Hcl ErVenlafaxine Hcl65$2,289
Vilazodone Hcl20$2,070
Bupropion XlBupropion Hcl50$1,329
Mirtazapine27$928
Fluoxetine Hcl51$864
Sertraline Hcl59$839
Clonazepam137$766
Lamotrigine63$738
Trazodone Hcl80$735

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$174$125,25511 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$182$3,68211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →